Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > COO Cooper Companies > Key Indicators
COO Cooper Companies
316.350
+8.910+2.90%
Post Mkt Price
316.3500.0000.00%
YOY
Do not show
Hide blank lines
(Q3)2022/07/31(Q2)2022/04/30(Q1)2022/01/31(FY)2021/10/31
Financial Ratios
Efficiency Ratios TTM
Cash Conversion Cycle(D)
-11.90% 196.9472 -10.52% 206.0476 -4.94% 217.7441 -2.04% 213.9086
Receivable Turnover(T)
3.39% 5.969 -0.81% 6.143 8.20% 6.1376 10.11% 6.1481
Inventory Turnover(T)
12.70% 1.8429 10.79% 1.8055 5.08% 1.7361 0.53% 1.6725
Fixed Assets Turnover(T)
9.42% 2.03 11.97% 1.968 15.33% 1.8904 2.17% 1.8575
Total Asset Rate(T)
-12.53% 0.3043 -11.87% 0.302 -7.65% 0.2943 -4.28% 0.3576
ROIC
-87.82% 4.902% -69.65% 10.316% -68.65% 10.275% 749.47% 40.636%
ROE
-88.77% 6.209% -70.09% 14.388% -68.58% 14.539% 755.06% 54.702%
ROA
-88.59% 4.069% -69.95% 9.118% -68.62% 9.122% 883.40% 36.035%
FCF to Sales
-11.95% 16.279% -0.22% 15.513% 112.50% 17.869% 147.46% 17.937%
FCF to Net Income
574.81% 121.742% 192.60% 51.377% 525.48% 57.653% -75.91% 17.802%
Efficiency Ratios
ROE 5 Year Average
-- -- -- -- -- -- 94.53% 18.313%
ROA 5 Year Average
-- -- -- -- -- -- 107.30% 11.555%
Average 5 Years ROIC
-- -- -- -- -- -- 92.63% 13.819%
Profitability Ratios TTM
Gross Margin
-0.95% 65.382% 1.76% 65.901% 5.63% 66.800% 6.00% 66.922%
Operating Margin
-1.41% 16.544% -6.95% 15.697% 22.57% 16.612% 34.93% 17.307%
Net Margin
-86.95% 13.372% -65.90% 30.194% -66.03% 30.995% 927.41% 100.760%
EBITDA Margin
-0.43% 0.2791% -4.23% 0.2742% 4.66% 0.2684% 16.08% 0.2819%
R & D Expense Ratio
2.15% 3.320% -2.97% 3.270% -14.13% 3.220% -17.45% 3.170%
Sales Expense Ratio
-- 0.000% -- 0.000% -- 0.000% -- 0.000%
Administration Expense Rate
-- 0.000% -- 0.000% -- 0.000% -- 0.000%
Financial Health Ratios
Long-Term Debt to Equity Ratio
73.29% 36.179% 44.37% 36.682% 34.81% 37.360% -44.66% 23.449%
Total Assets to Common Equity
15.15% 163.098% 14.81% 167.931% 13.05% 168.390% -21.45% 138.382%
Debt to Asset Ratio
59.10% 44.233% 53.44% 50.111% 45.96% 51.058% -53.37% 25.158%
Current Ratio
-16.26% 1.1614 -20.85% 1.0545 -24.41% 1.0202 57.77% 2.0015
Quick Ratio
-5.69% 0.5742 -5.91% 0.5649 -19.72% 0.4846 52.10% 0.8349
GrowthRatios
Growth Ratios
Revenue CAGR(3Y)
-- -- -- -- -- -- 12.16% 4.886%
Revenue CAGR(5Y)
-- -- -- -- -- -- 32.34% 8.243%
Net Income CAGR(3Y)
-- -- -- -- -- -- 1,371.20% 176.105%
Net Income CAGR(5Y)
-- -- -- -- -- -- 1,791.71% 60.799%
Dividend CAGR(3Y)
-- -- -- -- -- -- -- 0.000%
Dividend CAGR(5Y)
-- -- -- -- -- -- -- 0.000%
FCF 1 Year Growth
-- -- -- -- -- -- 439.60% 197.503%
FCF CAGR(3Y)
-- -- -- -- -- -- 111.97% 3.318%
FCF CAGR(5Y)
-- -- -- -- -- -- 124.50% 7.986%
Currency Unit
USDUSDUSDUSD

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.
CEO: Mr. Albert G. White, III
Market: NYSE
Listing Date: 01/21/1983
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist